Cellectar Biosciences (NASDAQ:CLRB) Coverage Initiated by Analysts at StockNews.com
StockNews.com assumed coverage on shares of Cellectar Biosciences (NASDAQ:CLRB – Free Report) in a report issued on Saturday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Cellectar Biosciences Trading Up 5.6 % Shares of CLRB opened at $0.30 on Friday. Cellectar Biosciences has a 52 week low of $0.22 and a […]
StockNews.com assumed coverage on shares of Cellectar Biosciences (NASDAQ:CLRB – Free Report) in a report issued on Saturday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Cellectar Biosciences Trading Up 5.6 % Shares of CLRB opened at $0.30 on Friday. Cellectar Biosciences has a 52 week low of $0.22 and a […]